Libbey S. O′Farrell
Impact in
-
- Diabetes Treatment and Management
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
Papers in
-
- Receptor Mechanisms and Signaling 4
- Metabolism, Diabetes, and Cancer 2
- Fibroblast Growth Factor Research 2
-
- Pharmacology and Obesity Treatment 5
- Co-authors
- Tamer Coşkun (15 shared papers)Axel Haupt (5 shared papers)Shweta Urva (5 shared papers)Daniel A. Briere (5 shared papers)Charles Benson (2 shared papers)Corina Loghin (2 shared papers)Andrew C. Adams (2 shared papers)Susan L. DuBois (2 shared papers)
- Journals
- Diabetes (4 papers)Molecular Metabolism (4 papers)Diabetes Obesity and Metabolism (3 papers)Cell Metabolism (2 papers)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Libbey S. O′Farrell
16 papers receiving 633 citations
Libbey S. O′Farrell's Hit Papers
Peers
Comparison fields: 5 of 66
- Endocrinology, Diabetes and Metabolism 299
- Endocrine and Autonomic Systems 81
- Physiology 256
- Pharmacology 151
- Molecular Biology 252
Countries citing papers authored by Libbey S. O′Farrell
This map shows the geographic impact of Libbey S. O′Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libbey S. O′Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libbey S. O′Farrell more than expected).
Fields of papers citing papers by Libbey S. O′Farrell
This network shows the impact of papers produced by Libbey S. O′Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libbey S. O′Farrell. The network helps show where Libbey S. O′Farrell may publish in the future.
Co-authors
The 25 scholars most cited alongside Libbey S. O′Farrell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Hit paper breakdown → | 2022 | 180 |
| 2 | 2018 | 167 | |
| 3 | 2020 | 92 | |
| 4 | 2013 | 68 | |
| 5 | 2019 | 30 | |
| 6 | 2023 | 19 | |
| 7 | Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation Hit paper breakdown → | 2025 | 18 |
| 8 | 2015 | 17 | |
| 9 | 2012 | 16 | |
| 10 | 2023 | 14 | |
| 11 | 2021 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2025 | 4 | |
| 14 | 2024 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2011 | 2 | |
| 17 | 2025 | 0 |
About Libbey S. O′Farrell
Libbey S. O′Farrell is a scholar working on Molecular Biology, Pharmacology, Endocrinology, Diabetes and Metabolism, Surgery and Physiology, having authored 17 papers that have together received 648 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Pharmacology and Obesity Treatment (5 papers), Adipose Tissue and Metabolism (5 papers), Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (3 papers), Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (299 citations), Endocrine and Autonomic Systems (81 citations), Physiology (256 citations), Pharmacology (151 citations) and Molecular Biology (252 citations). Libbey S. O′Farrell has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Tamer Coşkun, Axel Haupt, Shweta Urva, Daniel A. Briere, Charles Benson, Corina Loghin, Andrew C. Adams, Susan L. DuBois, Hongchang Qu and Jorge Alsina‐Fernandez. Their work appears in journals such as Diabetes, Molecular Metabolism, Diabetes Obesity and Metabolism, Cell Metabolism and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.